US2013231361A1PendingUtilityA1

4-hydroxybenzomorphans

Assignee: RENSSELAER POLYTECH INSTPriority: Nov 5, 2004Filed: Apr 15, 2013Published: Sep 5, 2013
Est. expiryNov 5, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61P 37/06A61P 3/04A61P 25/04A61P 25/36A61P 29/00A61P 25/02A61P 25/08A61P 25/30A61P 21/02A61P 1/00A61P 11/00A61P 11/14A61P 1/04A61P 17/04A61P 1/12C07D 215/20C07D 489/02C07D 221/26C07D 221/28C07D 215/14C07D 489/08C07D 489/00A61K 31/485
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. A compound of formula is disclosed, as are pharmaceutically acceptable acid addition salts, such as acetic, benzenesulfonic (besylate), benzoic, camphorsulfonic, citric, ethenesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric acid or p-toluenesulfonic acid salts. These compounds are useful for the treatment of pain.

Claims

exact text as granted — not AI-modified
I claim: 
     
         1 . A compound of formula: 
       
         
           
           
               
               
           
         
       
     
     
         2 . A pharmaceutically acceptable acid addition salt of a compound of formula: 
       
         
           
           
               
               
           
         
       
       wherein said salt is selected from acetic, benzenesulfonic (besylate), benzoic, camphorsulfonic, citric, ethenesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric acid or p-toluenesulfonic acid salt. 
     
     
         3 . A method of treating pain comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound of formula:

Join the waitlist — get patent alerts

Track US2013231361A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.